167 related articles for article (PubMed ID: 37509551)
1. Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer.
Boo Y; Chung JH; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Song W
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509551
[TBL] [Abstract][Full Text] [Related]
2. Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection.
Chiu ST; Cheng YT; Pu YS; Lu YC; Hong JH; Chung SD; Chiang CH; Huang CY
Front Oncol; 2021; 11():772182. PubMed ID: 34869007
[TBL] [Abstract][Full Text] [Related]
3. The prostate health index (PHI) density: Are there advantages over PHI or over the prostate-specific antigen density?
Garrido MM; Ribeiro RM; Pinheiro LC; Holdenrieder S; Guimarães JT
Clin Chim Acta; 2021 Sep; 520():133-138. PubMed ID: 34097882
[TBL] [Abstract][Full Text] [Related]
4. Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection.
Chen H; Qian Y; Wu Y; Shi B; Zhou J; Qu F; Gu Z; Ding J; Yu Y
Front Oncol; 2022; 12():864111. PubMed ID: 35463344
[TBL] [Abstract][Full Text] [Related]
5. Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL.
Ferro M; Crocetto F; La Civita E; Fiorenza M; Jannuzzi G; Carbone G; Sirica R; Sicignano E; Pagano G; Imbimbo C; Terracciano D
Prostate; 2024 May; ():. PubMed ID: 38798011
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study.
Wu B; Shao Y; Lin X; Hasi C; Jia W; Wang D; Cao X
Transl Androl Urol; 2023 Mar; 12(3):425-432. PubMed ID: 37032752
[TBL] [Abstract][Full Text] [Related]
7. Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate Biopsies.
Schulze A; Christoph F; Sachs M; Schroeder J; Stephan C; Schostak M; Koenig F
Urol Int; 2020; 104(3-4):181-186. PubMed ID: 32224611
[TBL] [Abstract][Full Text] [Related]
8. Utility of Prostate Health Index Density for Biopsy Strategy in Biopsy-Naïve Patients With PI-RADS v2.1 Category 3 Lesions.
Kim MJ; Park JJ; Kang KA; Park SY; Kim CK
J Magn Reson Imaging; 2024 Feb; ():. PubMed ID: 38299766
[TBL] [Abstract][Full Text] [Related]
9. Prostate Health Index density aids the diagnosis of prostate cancer detected using magnetic resonance imaging targeted prostate biopsy in Taiwanese multicenter study.
Chang CH; Yu PH; Hsieh PF; Hong JH; Chiang CH; Cheng HM; Wu HC; Huang CY; Lin TP
J Chin Med Assoc; 2024 Jun; ():. PubMed ID: 38829960
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of the prostate health index density and multiparametric magnetic resonance imaging in diagnosing clinically significant prostate cancer.
Chen Y; Xu D; Ruan M; Li H; Lin G; Song G
Investig Clin Urol; 2023 Jul; 64(4):363-372. PubMed ID: 37417561
[TBL] [Abstract][Full Text] [Related]
11. How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density.
Kim JY; Jeon SS; Chung JH; Lee SS; Park SW
Prostate Int; 2023 Sep; 11(3):167-172. PubMed ID: 37745905
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PHI and PHI Density for Prostate Cancer Detection in a Large Retrospective Caucasian Cohort.
Peters R; Stephan C; Jung K; Lein M; Friedersdorff F; Maxeiner A
Urol Int; 2022; 106(9):878-883. PubMed ID: 34433176
[TBL] [Abstract][Full Text] [Related]
13. The Value of the Prostate Health Index and Derived Indexes in the Diagnosis of Prostate Cancer with PI-RADS-3 Lesions.
Cui Y; Zhao J; Sun Y
Urol Int; 2023; 107(10-12):959-964. PubMed ID: 38011845
[TBL] [Abstract][Full Text] [Related]
14. Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
Druskin SC; Tosoian JJ; Young A; Collica S; Srivastava A; Ghabili K; Macura KJ; Carter HB; Partin AW; Sokoll LJ; Ross AE; Pavlovich CP
BJU Int; 2018 Apr; 121(4):619-626. PubMed ID: 29232037
[TBL] [Abstract][Full Text] [Related]
15. Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions.
Lee CU; Lee SM; Chung JH; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Song W
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077710
[TBL] [Abstract][Full Text] [Related]
16. Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection.
Barisiene M; Bakavicius A; Stanciute D; Jurkeviciene J; Zelvys A; Ulys A; Vitkus D; Jankevicius F
Biomed Res Int; 2020; 2020():9872146. PubMed ID: 32775459
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prostate-specific antigen isoform p2PSA and its derivates, %p2PSA, prostate health index and prostate dimension-adjusted related index in the detection of prostate cancer at first biopsy: an exploratory, prospective study.
Mearini L; Ferri C; Lazzeri M; Bini V; Nunzi E; Fiorini D; Costantini E; Manasse GC; Porena M
Urol Int; 2014; 93(2):135-45. PubMed ID: 24732975
[TBL] [Abstract][Full Text] [Related]
18. Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone?
Rius Bilbao L; Valladares Gomez C; Aguirre Larracoechea U; Pereira Arias JG; Arredondo Calvo P; Urdaneta Salegui LF; Escobal Tamayo V; Sanz Jaka JP; Recio Ayesa A; Mar Medina J; Mar Medina C
Clin Chim Acta; 2023 Mar; 542():117270. PubMed ID: 36893880
[TBL] [Abstract][Full Text] [Related]
19. The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men.
Chiu PK; Lam TY; Ng CF; Teoh JY; Cho CC; Hung HY; Hong C; Roobol MJ; Chu WC; Wong SY; Sung JJ
Asian J Androl; 2023 Nov; 25(6):674-679. PubMed ID: 37534902
[TBL] [Abstract][Full Text] [Related]
20. How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?
Zhang Y; Zeng N; Zhang F; Huang Y; Tian Y
Int J Clin Oncol; 2020 Jan; 25(1):175-186. PubMed ID: 31473884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]